These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9668168)

  • 21. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
    Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
    Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
    Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
    J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules.
    Xu H; Gutmann DH
    Brain Res; 1997 Jun; 759(1):149-52. PubMed ID: 9219873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurofibromatosis type 1: pathology, clinical features and molecular genetics.
    von Deimling A; Krone W; Menon AG
    Brain Pathol; 1995 Apr; 5(2):153-62. PubMed ID: 7670656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of two conserved arginine residues for catalysis by the ras GTPase-activating protein, neurofibromin.
    Sermon BA; Lowe PN; Strom M; Eccleston JF
    J Biol Chem; 1998 Apr; 273(16):9480-5. PubMed ID: 9545275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
    Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
    Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
    J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ras effector loop mutations that dissociate p120GAP and neurofibromin interactions.
    Stang S; Bottorff D; Stone JC
    Mol Carcinog; 1996 Jan; 15(1):64-9. PubMed ID: 8561868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.
    Ismat FA; Xu J; Lu MM; Epstein JA
    J Clin Invest; 2006 Sep; 116(9):2378-84. PubMed ID: 16906226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.
    Morcos P; Thapar N; Tusneem N; Stacey D; Tamanoi F
    Mol Cell Biol; 1996 May; 16(5):2496-503. PubMed ID: 8628317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of neurofibromatosis type 1 (NF1).
    Shen MH; Harper PS; Upadhyaya M
    J Med Genet; 1996 Jan; 33(1):2-17. PubMed ID: 8825042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
    Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
    Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the tyrosinase gene promoter by neurofibromin.
    Suzuki H; Takahashi K; Yasumoto K; Shibahara S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.
    Ballester R; Marchuk D; Boguski M; Saulino A; Letcher R; Wigler M; Collins F
    Cell; 1990 Nov; 63(4):851-9. PubMed ID: 2121371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae.
    Xu GF; Lin B; Tanaka K; Dunn D; Wood D; Gesteland R; White R; Weiss R; Tamanoi F
    Cell; 1990 Nov; 63(4):835-41. PubMed ID: 2121369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.